Nashat Gabrail

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti et al. · Journal of Clinical Oncology · 2008 · 1.8K citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim et al. · The Lancet Oncology · 2018 · 576 citations · Full text

Medicine, Oncology, Pharmacology +8

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

Adrian S. Dobs, Ralph V. Boccia, C. Croot et al. · The Lancet Oncology · 2013 · 383 citations

Medicine, Oncology, Pharmacotherapy +11

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification

Brendan Bulik‐Sullivan, Jennifer Busby, Christine D. Palmer et al. · Nature Biotechnology · 2018 · 310 citations

Medicine, Molecular Biology, Oncology +17